Unknown OBSERVATIONAL NCT01027091

The Study of a Safe and Cost-effective Method to Identify Patients at Low Risk of Significant Hypocalcemia After Total Thyroidectomy.

The Study of a Safe and Cost-effective Method to Identify Patients at Low Risk for the Development of Significant Hypocalcemia After Total Thyroidectomy.

Sponsor: G. Hatzikosta General Hospital

Conditions Hypocalcemia After Total Thyroidectomy

Updated 5 times since 2017 Last updated: Dec 4, 2009 Started: Nov 30, 2008 Primary completion: Jun 30, 2010 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01027091, this observational or N/A phase trial focuses on Hypocalcemia After Total Thyroidectomy and remains ongoing. Sponsored by G. Hatzikosta General Hospital, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

G. Hatzikosta General Hospital

Data source: G. Hatzikosta General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ioannina, Greece